Jin Medical International Ltd.
ZJYL | NASDAQ
$2.17
-$0.18 (-7.66%)
Nov 2, 2026, 1:10 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 75.33 | 114.47 | 59.09 | 19.88 | 40.56 | 72.27 |
PEG Ratio | -1.11 | 6.13 | -59.09 | 0.19 | 0.52 | -1.83 |
PS Ratio | 4.28 | 17.91 | 8.57 | 2.80 | 5.12 | 9.82 |
PB Ratio | 2.98 | 14.61 | 7.08 | 3.52 | 7.58 | 14.72 |
P/FCF Ratio | -23.74 | -180.53 | 56.75 | 34.83 | 18.33 | 67.35 |
P/OCF Ratio | 30.46 | -348.64 | 54.66 | 33.95 | 18.20 | 63.52 |
OCF/S Ratio | 14.04 | -5.14 | 15.67 | 8.24 | 28.14 | 15.46 |
Debt / Equity Ratio | 0.64 | 0.40 | 0.17 | n/a | n/a | 0.25 |
Quick Ratio | 1.65 | 2.08 | 2.83 | 2.11 | 1.57 | 1.09 |
Current Ratio | 1.86 | 2.50 | 3.49 | 3.31 | 2.47 | 1.81 |
Asset Turnover | 0.39 | 0.51 | 0.60 | 0.92 | 0.95 | 0.78 |
Interest Coverage | n/a | n/a | n/a | n/a | 277.23 | 20.95 |
Return on Equity | 4.02% | 12.76% | 12% | 17.76% | 18.76% | 20.42% |
Return on Assets | 2.23% | 8.03% | 8.75% | 12.93% | 12.02% | 10.60% |
Return on Invested Capital | 1.09% | 7.41% | 9.12% | 13.80% | 17.14% | 16.41% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 29.22% | 40.43% | 34.23% | 32.30% | 30.64% | 33.95% |
Net Profit Margin | 5.76% | 15.64% | 14.52% | 14.10% | 12.67% | 13.62% |
Pretax Profit Margin | 7.71% | 17.80% | 16.25% | 14.29% | 13.87% | 14.53% |
Operating Profit Margin | 2.94% | 15.48% | 14.47% | 11.10% | 12.67% | 14.54% |
FCF Margin | -18.01% | -9.92% | 15.10% | 8.03% | 27.93% | 14.58% |
EBITDA Margin | 4.51% | 16.96% | 15.61% | 16.15% | 15.56% | 17.23% |
Add to Watchlist
Select watchlists to add or remove ZJYL